Back to Results
First PageMeta Content
Testosterone / Gonadotropin-releasing hormone antagonist / Leuprorelin / Prostate cancer / Moxifloxacin / Gonadotropin-releasing hormone agonist / Hormone replacement therapy / Endocrine system / Medicine / Degarelix


ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.
Add to Reading List

Document Date: 2015-01-22 11:10:22

Open Document

File Size: 908,91 KB

Share Result on Facebook

Currency

pence / /

IndustryTerm

injection site / antiarrhythmic medicinal products / concomitant medicinal products / colourless solution / medicinal products / prostate cancer treatment / /

MedicalCondition

osteopenia / muscular weakness / necrosis / Hypertension / torsades de pointes / arthralgia / severe untreated asthma / Chills / Hyperglycemia / hepatic disorder / dysfunction / stroke / muscle spasms / tumour / diabetes / alopecia / Transient chills / erythema / fever / Contraindications Hypersensitivity / pain / Cardiac arrhythmia / vomiting / Fatigue / myocardial infarction / Diabetes mellitus / advanced hormone-dependent prostate cancer / Urticaria / angioedema / Osteoporosis / anaphylactic reactions / atrial fibrillation / infection / irritation / dizziness / prostate cancer / illness / Constipation / Depression / pruritus / severe urticaria / Cardiovascular disease Cardiovascular disease / influenza / abscess / hypotension / /

MedicalTreatment

hormonal therapy / prostatectomy / Endocrine therapy / drainage / radiotherapy / surgical treatment / surgery / radiation / /

Organization

Intramuscular administration / /

Position

General / /

Product

testosterone / /

Technology

pharmacokinetics / radiation / antibodies / ultrasound / /

SocialTag